SHSE:603102 (China)
Â
Class A
Â¥
31.3
+0.60 (+1.95%)
Jul 27
Business Description
Weihai Baihe Biology Technological Co Ltd
ISIN : CNE100005RB6
Share Class Description:
SHSE:603102: Class ATotal Employee Number:
1,096Compare
Compare
Traded in other countries / regions
603102.China Index Membership
SSE Composite Index IPO Date
2022-01-25Description
Weihai Baihe Biology Technological Co Ltd is engaged in the research and development, production and sales of nutritional health food.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 70.7 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.1 | |||||
Interest Coverage | 353.53 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.92 | |||||
Beneish M-Score | -1.76 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.1 | |||||
3-Year EBITDA Growth Rate | -7.7 | |||||
3-Year EPS without NRI Growth Rate | -9.9 | |||||
3-Year FCF Growth Rate | -18 | |||||
3-Year Book Growth Rate | 19.1 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.81 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.44 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.2 | |||||
9-Day RSI | 42.56 | |||||
14-Day RSI | 41.45 | |||||
3-1 Month Momentum % | -21.24 | |||||
6-1 Month Momentum % | -30.2 | |||||
12-1 Month Momentum % | -28.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.58 | |||||
Quick Ratio | 5.95 | |||||
Cash Ratio | 5.03 | |||||
Days Inventory | 77.25 | |||||
Days Sales Outstanding | 31.98 | |||||
Days Payable | 63.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.38 | |||||
Dividend Payout Ratio | 0.35 | |||||
Forward Dividend Yield % | 2.38 | |||||
5-Year Yield-on-Cost % | 2.38 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | 1.91 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.8 | |||||
Operating Margin % | 16.39 | |||||
Net Margin % | 12.78 | |||||
EBITDA Margin % | 15.75 | |||||
FCF Margin % | 10.33 | |||||
OCF Margin % | 15.25 | |||||
ROE % | 7.38 | |||||
ROA % | 6.39 | |||||
ROIC % | 20.96 | |||||
3-Year ROIIC % | -13.41 | |||||
ROC (Joel Greenblatt) % | 30.91 | |||||
ROCE % | 8.85 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.97 | |||||
Forward PE Ratio | 15.09 | |||||
PE Ratio without NRI | 14.44 | |||||
Price-to-Owner-Earnings | 35.81 | |||||
PEG Ratio | 4.98 | |||||
PS Ratio | 2.04 | |||||
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.26 | |||||
Price-to-Free-Cash-Flow | 19.31 | |||||
Price-to-Operating-Cash-Flow | 13.19 | |||||
EV-to-EBIT | 6.38 | |||||
EV-to-EBITDA | 6.38 | |||||
EV-to-Revenue | 1 | |||||
EV-to-FCF | 9.72 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 1.01 | |||||
Price-to-Graham-Number | 0.9 | |||||
| Price-to-Net-Current-Asset-Value | 1.74 | |||||
| Price-to-Net-Cash | 2.46 | |||||
Earnings Yield (Greenblatt) % | 15.67 | |||||
FCF Yield % | 4.93 | |||||
Forward Rate of Return (Yacktman) % | 0.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Weihai Baihe Biology Technological Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 955.877 | ||
| EPS (TTM) (Â¥) | 1.96 | ||
| Beta | 0.7782 | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.65 | ||
| Volatility % | 20.51 | ||
| 14-Day RSI | 41.45 | ||
| 14-Day ATR (Â¥) | 1.161129 | ||
| 20-Day SMA (Â¥) | 32.2655 | ||
| 12-1 Month Momentum % | -28.67 | ||
| 52-Week Range (Â¥) | 30.46 - 51.84 | ||
| Shares Outstanding (Mil) | 64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Weihai Baihe Biology Technological Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Weihai Baihe Biology Technological Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.750000 Cash Dividend | 2025-08-05 | 43.47 (+1.64%) |
Show
Entries
Weihai Baihe Biology Technological Co Ltd Frequently Asked Questions
What is Weihai Baihe Biology Technological Co Ltd(SHSE:603102)'s stock price today?
The current price of SHSE:603102 is ¥31.30. The 52 week high of SHSE:603102 is ¥51.84 and 52 week low is ¥30.46.
When is next earnings date of Weihai Baihe Biology Technological Co Ltd(SHSE:603102)?
The next earnings date of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) is .
Does Weihai Baihe Biology Technological Co Ltd(SHSE:603102) pay dividends? If so, how much?
The Dividend Yield %  of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) is 2.38% (As of Today), Highest Dividend Payout Ratio of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) was 0.37. The lowest was 0.24. And the median was 0.24. The  Forward Dividend Yield % of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) is 2.38%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Weihai Baihe Biology Technological Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers